Navigation Links
Zydus Cadila and Kopran in strategic alliance

The Ahmedabad-based Zydus Cadila Healthcare announced a strategic alliance with Mumbai-based Kopran for marketing and manufacturing of formulation brands and collaborative research while taking over the Kopran's anti-hypertensive drug 'Aten' for Rs. 75 crores. Aten (Atenolol), is the largest brand in the cardiovascular segment. Aten, today, ranks within the top 50 Indian Pharma brands.

// As a part of the alliance, the Mumbai-based Kopran has perpetually assigned its anti-hypertensive drug 'Aten'(Atenol) to Zydus Cadila for a consideration of Rs. 75 crores but will continue to manufacture the drug at its facility, Zydus Cadila release said here. Zydus has also entered into a seperate technology transfer agreement with Kopran for zero impurity Atenol which includes milestone payments totalling Rs. 20 crores.

"We saw Aten as a good fit in terms of its size and presence in the cardiac care market," Mr.Pankaj, Managing Director, Zydus Cadila said. Mr.Surendra Somani, MD, Kopran said, "while Aten would grow faster in the hands of Zydus, Kopran would be able to acheive higher growths through its strategy of launching new products."

Kopran will also co-market Zydus Cadila's new products in diabetes, central nervous system and other speciality segments including brands Olanzapine(Olzep), Zolipidem(Zopiz) and anti-diabetic Glimepiride(Gliran).

Zydus Cadila has been leveraging its strength in new product development to introduce several new products, many of them for the first time in India. While on one hand Aten would grow faster in the hands of Zydus Cadila, Kopran would be able to achieve higher growths through its strategy of launching new products.


'"/>




Page: 1

Related medicine news :

1. Cadila gets US FDA approval for Promethazine tablets
2. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
3. Cadila to Commence Phase I Clinical Trials On ZYH2
4. A strategic study: Soy diet makes heart disease to worsen in male mice
5. Pharma cos must forge Strategic alliances
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2017)... ... April 22, 2017 , ... The San Juan Capistrano summer camp team ... report outlining the need for summer camps to provide physical activities for all campers. To ... Activity In Summer Camps , With an increase in specialty camps that focus on what ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... Christopher Salas-Wright finds that youth violence is declining—and at noteworthy rates. Between 2002 ... proportion of young people involved in violence in the United States. The study, ...
(Date:4/21/2017)... ... April 21, 2017 , ... Young Asset Protection, an insurance ... throughout the greater Pittsburgh metropolitan region, is joining forces with the local chapter ... differently-abled children. , Variety the Children’s Charity is a national organization dedicated to ...
(Date:4/21/2017)... ... April 21, 2017 , ... The VIA ... Record (AOR) for Theravent, Inc. , the makers of a revolutionary new ... Consumer Healthcare, is now working to expand distribution in anticipation of a national ...
(Date:4/21/2017)... ... April 21, 2017 , ... Alive for Wellness is a group ... mental health struggles. The Alive team uses advanced behavioral sciences treatment modalities to ... with a mental health struggle is based on 10 modalities of treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... 1 fiscal 2017 earnings per share (EPS) guidance ... 2019.  This is in conjunction with this morning,s announcement ... Vein Thrombosis and Nutritional Insufficiency businesses. Cardinal ... continuing operations will be at the bottom of its ...
Breaking Medicine Technology: